After the broad approval by European health authorities in June 2013, the company has received a total of nine national phase approvals for Vitaros, including Luxembourg, Belgium, France,
The sanctions against the company relate to part of its promotional activities regarding CASE-J which were inviolation of the ‘Prescription Drugs Promotion Code’ of the JPMA and as
The POC study is a Phase I/II trial of 24 patients with steroid-resistant GVHD following allogeneic bone-marrow stem cell transplant who will receive six to ten doses of
With the approval, Kalbitor is the first and only subcutaneous therapy available to treat acute attacks of HAE in patients 12 years of age and older. The drug
Latuda, the antipsychotic agent, has been marketed for the treatment of schizophrenia in Canada by Sunovion Pharmaceuticals Canada, a subsidiary of the US-based Sunovion Pharmaceuticals. The company said
Novaliq claims that CyclASol is the first and only 0.05% clear cyclosporin solution, which is available in multi-dose and preservative free bottles to treat dry eye syndrome. Developed
The MAA validation confirms that the submission is sufficiently complete to start the formal review process. The EMA’s review of the MAA will follow the centralized marketing authorization
Currently, the company is evaluating the safety and efficacy of eravacycline in a Phase III clinical program, which includes two trials. The IGNITE 1 trial is assessing the
In the US, Canada, Japan and Russia, simeprevir is approved to treat genotype 1 HCV as part of an antiviral treatment regimen in combination with pegylated interferon and
The company secured the certification for its new supplement format designed specifically for children called Kidi Bites. Anlit Marketing VP Shai Karlinski said the company approached this certification
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.